News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



Long-term safety of GnRHa affirmed in premenopausal women undergoing chemo for breast cancer

By Marilynn Larkin NEW YORK (Reuters Health) - In premenopausal women with early breast cancer, use of a gonadotropin-releasing hormone agonist (GnRHa) during chemotherapy did not increase the risk of

Dengue, chikungunya and zika virus incidence in Mexico likely higher than previously thought

By Marilynn Larkin NEW YORK (Reuters Health) - More accurate testing reveals that the incidence of dengue (DENV), chikungunya (CHIKV) and zika (ZIKAV) viruses in endemic areas of Mexico is likely

Pfizer COVID-19 vaccine partially protective against Omicron - Bloomberg News

By Reuters Staff (Reuters) - The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech's COVID-19 vaccine, Bloomberg News reported on Tuesday,

Fauci says early evidence points to Omicron being more transmissible but less severe

By Ahmed Aboulenein and Susan Heavey WASHINGTON (Reuters) - Preliminary evidence indicates that the Omicron variant of the coronavirus likely has a higher degree of transmissibility but is less severe

Poor nations lag in removing unhealthy trans fat from food - WHO report

By Stephanie Nebehay GENEVA (Reuters) - Richer countries are making progress in eliminating harmful trans fat from diets by next year, but poorer nations with the highest toll of heart disease due to

Denmark sees 'society-wide infection' with Omicron variant

By Reuters Staff COPENHAGEN (Reuters) - The new Omicron coronavirus variant has spread across Denmark, health authorities said on Tuesday after registering large outbreaks of the variant in the east

EXCLUSIVE-Up to 1 million COVID vaccines wasted in Nigeria last month

By Edward McAllister, Libby George and Stephanie Nebehay DAKAR (Reuters) - Up to one million COVID-19 vaccines are estimated to have expired in Nigeria last month without being used, two sources told

New diagnostic strategy for suspected pulmonary embolism shows promise

By Reuters Staff NEW YORK (Reuters Health) - For patients in the emergency department with suspected pulmonary embolism (PE) not ruled out by the PE rule-out criteria (PERC), a diagnostic strategy

USPSTF reaffirms advice on preventing cavities in preschoolers

By Reuters Staff NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend that pediatricians and other primary-care doctors apply fluoride varnish to infants

Medicago's plant-based vaccine trial shows 75.3% efficacy against Delta variant

By Reuters Staff (Reuters) - Canadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's adjuvant, was 75.3% effective against the Delta variant of the

Medicago's plant-based vaccine trial shows 75.3% efficacy against Delta variant

By Reuters Staff (Reuters) - Canadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's adjuvant, was 75.3% effective against the Delta variant of the

Medicago's plant-based vaccine trial shows 75.3% efficacy against Delta variant

By Reuters Staff (Reuters) - Canadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's adjuvant, was 75.3% effective against the Delta variant of the

High-flow nasal oxygen has benefits in severe COVID-19

By Reuters Staff NEW YORK (Reuters Health) - Hospitalized patients with severe COVID-19 infection can benefit from high-flow nasal oxygen with less need for intubation and earlier recovery, according

Many not receiving statins after lower-extremity revascularization

By Linda Carroll NEW YORK (Reuters Health) - More than two-thirds of patients who were not already taking a statin prior to lower-extremity revascularization were not given the cholesterol-lowering

Pre-op chemosensitivity tied to post-op survival in patients with gastric tumors

By Lorraine L. Janeczko NEW YORK (Reuters Health) - How long patients with resected gastric adenocarcinoma survive is tied to their preoperative sensitivity to chemotherapy, researchers report. "

New data shows GSK-Vir drug works against all Omicron mutations

By Reuters Staff (Reuters) - British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology is effective against all spike mutations in the new Omicron

Africa needs to make own vaccines but hurdles are high, experts say

By Clement Uwiringiyimana KIGALI (Reuters) - Africa needs to make its own vaccines to avoid a repeat of its supply problems in the COVID-19 pandemic but faces big obstacles in turning itself from a

Britain suffers record rise in alcohol deaths during COVID pandemic

By Reuters Staff LONDON (Reuters) - The United Kingdom saw a record rise in the number of deaths caused by alcohol misuse last year, which public health officials said was linked to the wider social

Investors push food & drink companies, govts over 'nutrition crisis'

By Simon Jessop LONDON (Reuters) - Investors managing $12.4 trillion in assets on Tuesday called for governments and companies to accelerate the shift to promoting healthier food and drink to help fix

EU may face shortage of key materials for diagnostics, cancer treatments

By Francesco Guarascio BRUSSELS (Reuters) - The European Union may face a shortage of radioactive isotopes key to diagnosing a range of diseases and treating cancer, according to officials and

Vaccine mandates 'absolute last resort', WHO Europe head says

By Reuters Staff COPENHAGEN (Reuters) - Mandatory vaccinations against the coronavirus are an "absolute last resort", the World Health Organization's top Europe official said on Tuesday. More and more

EU agencies endorse mix-and-match of COVID-19 vaccines

By Pushkala Aripaka (Reuters) - EU health agencies have recommended that COVID-19 vaccines be mixed and matched for both initial courses and booster doses as the region battles rising cases ahead of

Shorter course, high-dose rifampin promising for implant-associated bone infections

By Marilynn Larkin NEW YORK (Reuters Health) - In orthopedic-implant associated bone infections in mice, shorter courses of high-dose rifampin penetrated bone tissue infected with Staphylococcus

EU regulator backs Roche's arthritis drug for treating severe COVID-19

By Reuters Staff (Reuters) - The European Union's drug regulator on Monday recommended extending the use of Roche's RoActemra arthritis drug for adult COVID-19 patients on systemic treatment with

England has community transmission of Omicron variant, health minister says

By Reuters Staff (Reuters) - Britain's health minister said on Monday there is now community transmission of the Omicron variant of the coronavirus across regions of England but it is too early to say

Malaria deaths rise by 69,000 in 2020 due to COVID-19 disruptions, says WHO

By Reuters Staff (Reuters) - Healthcare disruptions linked to the coronavirus pandemic helped malaria kill 69,000 more people in 2020 than the previous year, but a worst-case scenario was averted, the

Israeli data indicates strong Pfizer booster protection

By Reuters Staff (Reuters) - A booster shot of the Pfizer/BioNTech COVID-19 vaccine appears to provide strong protection, at least in the short term, according to data from Israel. The odds of testing

Apixaban tops rivaroxaban for repeat-VTE protection in real-world analysis

By Reuters Staff NEW YORK (Reuters Health) - Apixaban appears to be safer and more effective than rivaroxaban in adults with venous thromboembolism (VTE) starting a direct oral anticoagulant (DOAC),

Retinopathy risk likely greater in children with T2DM vs T1DM

By Marilynn Larkin NEW YORK (Reuters Health) - Children with type 2 diabetes (T2D) had almost twice the risk of developing retinopathy compared with those with type 1 diabetes (T1D) in a retrospective

Cancer patients benefit from mRNA vaccines

By Reuters Staff (Reuters) - Although people with cancer generally do not have the typical strong immune response to COVID-19 vaccines, they still benefit from the shots, according to new data.

Intravenous COVID-19 antibody cocktail might be injectable

By Reuters Staff (Reuters) - The intravenous antibody cocktail sold by Regeneron Pharmaceuticals Inc (casirivimab/imdevimab) might work just as well if administered by injection under the skin, a new

High-frequency spinal cord stimulation provides lasting relief of painful diabetic neuropathy

By Megan Brooks NEW YORK (Reuters Health) - High-frequency (10 kHz) spinal cord stimulation (SCS) provides durable pain relief in patients with painful diabetic neuropathy (PDN) who don't respond to

Major elective surgery may be safest eight or more weeks after COVID-19 infection

By Linda Carroll NEW YORK (Reuters Health) - Patients wanting to have major elective surgery after a SARS-CoV-2 infection may be less likely to have postoperative complications, such as pneumonia,

Novartis working on pan-coronavirus oral treatment, CEO says

By Reuters Staff (Reuters) - Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly against coronaviruses, not just the

Namibia detects Omicron coronavirus variant in 18 of 19 samples

By Reuters Staff (Reuters) - Namibia has detected the Omicron coronavirus variant in 18 of 19 samples sequenced between Nov. 11-26, its health ministry said on Monday. Although the southern African

Biohaven's migraine therapy shows rapid pain relief in late-stage study

By Reuters Staff (Reuters) - Biohaven Pharmaceutical said on Monday its intranasal spray for migraine met the main goals in the drugmaker's late-stage study, showing rapid pain relief. The study,

Negative confirmatory trial did little to drive down use of questionable preterm drug

By Megan Brooks NEW YORK (Reuters Health) - Use of hydroxyprogesterone caproate injection (Makena) for recurrent preterm birth remained high in the U.S. after a "confirmatory" clinical trial failed to

Is recovery of sexual function after radical prostatectomy surgeon dependent?

By Reuters Staff NEW YORK (Reuters Health) - Whether or not men have good sexual-function outcomes after radical prostatectomy may depend on the surgeon, according to a study that found substantial

Omicron variant may have picked up a piece of common-cold virus

By Nancy Lapid NEW YORK (Reuters) - The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus -

Pre-eclampsia/eclampsia tied to increased risk of heart failure for at least 10 years

By Marilynn Larkin NEW YORK (Reuters Health) - Women with pre-eclampsia/eclampsia were at increased risk for future heart failure (HF) for up to a decade in a large cohort study. "While preeclampsia

Fat cell alterations implicated in breast cancer metastases

By Marilynn Larkin NEW YORK (Reuters Health) - In preclinical experiments, researchers have uncovered a mechanism linking fat cells altered by type 2 diabetes or insulin resistance to breast cancer

At least one year on bisphosphonates needed for fracture prevention

By Lisa Rapaport (Reuters Health) - It takes 12.4 months of bisphosphonate therapy to prevent one nonvertebral fracture per 100 postmenopausal women with osteoporosis, a meta-analysis of randomized

REUTERS NEXT-Researcher questions China's population data, says it may be lower

By Jane Lanhee Lee (Reuters) - China may be downplaying how fast its population is shrinking, and a recent policy to promote three-child families has poor chances to improve birth rates, a fertility

FDA clears use of Lilly's COVID-19 antibody therapy for kids

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children,

EXPLAINER-Could the Omicron variant bring milder illness?

By Deena Beasley (Reuters) - The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of

Omicron outbreak at Norway Christmas party is biggest outside S. Africa -authorities

By Gwladys Fouche and Nerijus Adomaitis OSLO (Reuters) - At least 13 people in Oslo have been infected with the Omicron variant of the coronavirus following a corporate Christmas party described as a

Valneva says no conclusions should be drawn on its vaccine from UK booster study

By Reuters Staff PARIS (Reuters) - French biotech firm Valneva said on Friday no conclusions should be drawn on the effectiveness of its COVID-19 vaccine by a British study, which found it was the

Artificial heart maker Carmat suspends implants due to quality issue

By Reuters Staff (Reuters) - French medical device company Carmat on Friday said it had suspended implants of its Aeson artificial hearts following a quality issue affecting some of its prostheses. "

Researchers find 'promising' blood biomarkers for cognitive decline in dementia

By Lorraine L. Janeczko NEW YORK (Reuters Health) - In dementia with Lewy bodies (DLB), plasma levels of phosphorylated-tau - p-tau181 and p-tau231 - may be accessible, cost-effective biomarkers for

Roche develops new research test kits for Omicron variant

By Brenna Hughes Neghaiwi ZURICH (Reuters) - Roche's newly acquired subsidiary TIB Molbiol has developed three new test kits to help researchers detect mutations in the new Omicron variant of

Bayer's Nubeqa drug improves survival in prostate cancer trial

By Ludwig Burger FRANKFURT (Reuters) - Bayer said a combination therapy including its Nubeqa drug was shown to prolong the lives of men suffering from metastatic prostate cancer in a clinical study,

IDSA advises eye protection as part of health worker PPE for suspected or known COVID patients

By Reuters Staff NEW YORK (Reuters Health) - In updated guidance, the Infectious Disease Society of America (IDSA) suggests that healthcare personnel caring for patients with suspected or known COVID-

Few doctor's offices provide accommodations for patients with significant vision impairment

By Linda Carroll NEW YORK (Reuters Health) - Just 10% of doctor's offices in the U.S. provide two basic accommodations - describing the clinic space and offering materials in large font - for patients

Lowering of CRC-screening age likely to affect colonoscopy demand, case mix, adenoma detection

By Reuters Staff NEW YORK (Reuters Health) - The recent lowering of colorectal cancer (CRC)-screening age from 50 to 45 years is likely to affect demand for colonoscopy and case mix, and result in a

Genetic subtype of lymphoma determines ibrutinib response

By Matthew Phelan NEW YORK (Reuters Health) - Younger patients with two genetic subtypes of diffuse large B-cell lymphoma (DLBCL) - MCD and N1 - had a three-year survival of 100% in the phase-3

Experimental malaria vaccine continues to show promise

By Reuters Staff NEW YORK (Reuters Health) - A study conducted in West Africa confirms the protective efficacy of an experimental malaria vaccine against naturally occurring infection and shows it can

Italian anti-vaxxer tries to get COVID-19 jab in fake arm

By Reuters Staff ROME (Reuters) - An Italian man turned up at a vaccination centre wearing a fake silicone arm, hoping to fool a nurse into giving him a jab in order to obtain a COVID-19 health

England's COVID-19 prevalence rises, led by Delta not Omicron

By Reuters Staff LONDON (Reuters) - The prevalence of COVID-19 infections in England rose to around 1 in 60 people in the week ending Nov. 27, Britain's Office for National Statistics said on Friday,

Geneva places 2,000 people in quarantine after two Omicron cases

By Brenna Hughes Neghaiwi ZURICH (Reuters) - The Swiss cantons of Geneva and Vaud have placed 2,000 people, most of them children, into quarantine after two cases of the Omicron variant were detected

REUTERS NEXT-WHO chief scientist says Omicron 'quite infectious', must not panic

By Francesco Guarascio and Stephanie Nebehay (Reuters) - The World Health Organization's chief scientist Soumya Swaminathan told the Reuters Next conference on Friday that while the new coronavirus

UK study finds mRNA COVID-19 vaccines provide biggest booster impact

By Alistair Smout LONDON (Reuters) - COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a

Verubecestat promising for glioblastoma

By Marilynn Larkin NEW YORK (Reuters Health) - Verubecestat, a beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) inhibitor originally developed to treat Alzheimer's disease, showed promise

Extracoronary vascular events likely rare after spontaneous coronary artery dissection

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with spontaneous coronary artery dissection (SCAD), severe vascular events were rare in a case series with five-year follow-up. "SCAD is a

Enriched infant formula does not improve later academic performance

By Lisa Rapaport (Reuters Health) - Giving infants nutritionally enriched baby formula won't lead to better grades in English or math during adolescence, a recent study suggests. Researchers examined

Omicron COVID-19 variant found in three U.S. states

By Kanishka Singh and Susan Heavey (Reuters) - Three U.S. states have found cases of the Omicron coronavirus variant -- California, Colorado and Minnesota -- among patients who were fully vaccinated

ANALYSIS-Trump's U.S. Supreme Court appointees poised to deliver on abortion

By Andrew Chung and Lawrence Hurley WASHINGTON (Reuters) - The month before being elected president in 2016, Donald Trump promised during a debate with his opponent Hillary Clinton to name justices to

S.Africa's health body sees threefold higher risk of reinfection from Omicron

By Reuters Staff JOHANNESBURG (Reuters) - The new Omicron variant of the coronavirus poses a threefold higher risk of reinfection than the currently dominant Delta variant and the Beta strain, a group

EU regulator begins real-time review of Valneva's COVID-19 shot

By Reuters Staff (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the inactivated-virus COVID-19 vaccine from French biotech firm Valneva, weeks

UPDATE 1-Israel halts disputed Omicron tracing through phone surveillance

(Recasts for halt to practice, updates case figures) By Reuters Staff JERUSALEM (Reuters) - Israel said on Thursday it was halting the use of mobile phone tracing to curb the spread of the new

FACTBOX-U.S. Omicron plan: boosters, free at-home tests, tighter travel rules

By Reuters Staff WASHINGTON (Reuters) - The Biden administration is seeking to ramp up its pandemic response amid the official arrival of the Omicron coronavirus variant, laying out a plan on Thursday

UPDATE 1-Omicron may become dominant in Europe in months -EU

(Adds details throughout) By Reuters Staff BRUSSELS (Reuters) - The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID

Psoriasis tied to small increase in risk of venous thromboembolism, peripheral vascular disease

By Linda Carroll NEW YORK (Reuters Health) - Venous thromboembolism (VTE) and peripheral vascular disease (PVD) may be slightly more likely to develop among patients with psoriasis than those without

Second U.S. Omicron variant case identified in Minnesota

By Reuters Staff (Reuters) - A case of the Omicron coronavirus variant was identified in Minnesota on Thursday, the U.S. state's health department said, with the identification coming a day after the

'Milestone' in stem-cell-based islet replacement for type-1 diabetes

By Reuters Staff NEW YORK (Reuters Health) - Interim results from an ongoing multicenter clinical trial show that implanted pluripotent-stem-cell-derived endocrine progenitor cells can secrete insulin

SPECIAL REPORT-U.S. rushed contracts to COVID-19 suppliers with troubled plants

By Marisa Taylor WASHINGTON (Reuters) - As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to

Israel's top court rejects petition against Omicron phone tracking

By Reuters Staff JERUSALEM (Reuters) - Israel's Supreme Court on Thursday rejected a petition by rights groups seeking to repeal temporary measures allowing the domestic intelligence agency to use

Third mRNA vaccine dose boosts immunity against SARS-CoV-2 variants in transplant recipients

By Lorraine L. Janezko NEW YORK (Reuters Health) - In organ transplant recipients, a third dose of the Moderna COVID-19 vaccine appears to increase neutralizing antibody response against SARS-CoV-2

Moderate COVID-19 infection in pregnancy unlikely to harm the fetal brain

By Megan Brooks NEW YORK (Reuters Health) - Mild to moderate COVID-19 infection during pregnancy appears to have no harmful effect on the brain of the developing fetus, according to a small study. "

Prenatal alcohol exposure alters fetal brain structure

By Megan Brooks NEW YORK (Reuters Health) - Radiologists observed significant changes in the brain structure of fetuses exposed to alcohol in the first MRI-based study to investigate the issue. "We

Finland to limit children's COVID-19 vaccines to high-risk households

By Essi Lehto HELSINKI (Reuters) - Children in Finland aged five and over should be vaccinated against COVID-19 if they or someone in their household are at high risk of severe infection, the Finnish

New Delhi shuts schools, colleges again due to air pollution

By Reuters Staff NEW DELHI (Reuters) - India's capital New Delhi has ordered the closure of schools and colleges until further notice from Friday after the Supreme Court criticised the city government

Omicron may soon cause over half of COVID infections in Europe -EU

By Reuters Staff BRUSSELS (Reuters) - The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID-19 infections in Europe

GSK says tests indicate antibody drug works against Omicron

By Ludwig Burger (Reuters) - Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new

S.Africa sees rise in COVID reinfections from Omicron, mild symptoms - scientist

By Katharine Houreld and Ayenat Mersie NAIROBI (Reuters) - South Africa is seeing an increase in COVID-19 reinfections due to the Omicron variant but symptoms for reinfected patients and those

Structured exercise aids arm function after breast cancer surgery

By Lisa Rapaport (Reuters Health) - Women who have non-reconstructive breast cancer surgery may experience better arm function when they follow a structured exercise program in addition to usual care,

Cytoreductive surgery beneficial when ovarian cancer recurs

By Reuters Staff NEW YORK (Reuters Health) - Adding cytoreductive surgery to chemotherapy can help women with recurrent ovarian cancer live nearly eight months longer than chemotherapy alone,

Biden seeks end to AIDS epidemic in the United States by 2030

By Jarrett Renshaw and Nandita Bose (Reuters) - U.S. President Joe Biden on Wednesday unveiled an updated national strategy to combat the AIDS epidemic with a goal of ending it by 2030. "We are within

Antihistamines linked to better immunotherapy response in cancer patients

By Marilynn Larkin NEW YORK (Reuters Health) - In cancer patients receiving immunotherapy, antihistamine drugs may improve outcomes, retrospective and preclinical analyses suggest. "We know some

Rituximab likely raises risk of hospital death in COVID-19 patients

By Marilynn Larkin NEW YORK (Reuters Health) - In hospitalized COVID-19 patients on immunosuppressive therapy, only those taking rituximab had an increased risk of in-hospital death in a retrospective

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.